Influence of CYP2C19 genotype on the pharmacokinetics of R483, a CYP2C19 substrate, in healthy subjects and type 2 diabetes patients

R483 is a thiazolidinedione peroxisome proliferator-activated receptor gamma (PPAR gamma) agonist with anti-diabetic properties and also a cytochrome P450 2C19 (CYP2C19) substrate. The aim of the clinical studies reported here was to investigate the influence of the CYP2C19 genotype on the pharmacok...

Full description

Saved in:
Bibliographic Details
Main Authors: Bogman, K., Silkey, M., Chan, S.P., Tomlinson, B., Weber, C.
Format: Article
Published: Springer Verlag (Germany) 2010
Subjects:
Online Access:http://eprints.um.edu.my/12236/
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items